| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 2,000 | ₹0.75 0% | 5,1750% |
| - | - | 2,100 | ₹1.2 0% | 6,5250% |
| 1,1250% | ₹284 9.29% | 2,200 | ₹3.55 7.57% | 24,975-0.89% |
| - | - | 2,250 | ₹5.8 13.72% | 19,80046.66% |
| 9000% | ₹172.5 0% | 2,300 | ₹10.4 14.28% | 48,3750.46% |
| 2250% | ₹136.05 0% | 2,350 | ₹19.7 19.75% | 33,7506.38% |
| 10,1259.75% | ₹100.2 -10.29% | 2,400 | ₹33 15.99% | 53,775-8.42% |
| 29,250-9.72% | ₹70.15 -12.36% | 2,450 | ₹53.2 16.66% | 47,700-5.35% |
| 96,75015.59% | ₹49 -12.5% | 2,500 | ₹80.8 11.44% | 46,8008.90% |
| 53,550164.44% | ₹33.4 -13.58% | 2,550 | ₹114.15 13.75% | 7,20018.51% |
| 2,02,05038.58% | ₹22.2 -11.2% | 2,600 | ₹141 -0.77% | 22,2757.60% |
| 48,60018.68% | ₹15.15 -11.66% | 2,650 | ₹184.2 0% | 6,5250% |
| 1,26,450-2.76% | ₹10.2 -10.91% | 2,700 | ₹229 0% | 10,5750% |
| 17,77512.85% | ₹7.75 -3.72% | 2,750 | ₹277 0% | 2250% |
| 93,3756.68% | ₹5.35 -2.72% | 2,800 | - | - |
| 1,575-36.36% | ₹3.4 0% | 2,850 | - | - |
| 10,350-64.61% | ₹3.1 67.56% | 2,900 | - | - |
| 2,0250% | ₹2 0% | 3,000 | - | - |
The company also informed that its diluted earnings per share (EPS) slipped by 20.10% on a yearly basis to ₹10.60.
Here are some of the stocks that may see significant price movement today: Coal India, Mankind Pharma, Swiggy, etc.
The business said that it logged a 10.70% year-on-year decline in its consolidated net profit at ₹420.80 Crore for Q4FY25.
Here are some of the stocks that may see significant price movement today: NBCC, IndusInd Bank, Hindustan Zinc, etc.
The cumulative demand, including interest charges, is ₹183.11 crore.
The merger took effect on March 29, 2025, after all necessary regulatory approvals were obtained.
The tax adjustments pertain to Section 80IC/80IE, which involves deductions for businesses in special economic zones, and a disallowance of certain expenditures under Section 37(1) of the Act.
Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.
The company reported a good growth in EBITDA of 36.8% to ₹830 crore in the quarter against ₹606.5 crore in Q3 FY24.
The NCDs issued are categorized, rated, secured, redeemable, and transferable, distributed across three series.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
